Literature DB >> 11920632

Promoter hypermethylation of the EDNRB gene in nasopharyngeal carcinoma.

Kwok-Wai Lo1, Yuen-Shan Tsang, Joseph Kwong, Ka-Fai To, Peter M L Teo, Dolly P Huang.   

Abstract

To identify the epigenetic changes in nasopharyngeal carcinoma (NPC), we performed methylation-sensitive restriction fingerprinting (MSRF) analysis on NPC cell lines and xenografts. A 190 bp sequence methylated in NPC tumors was isolated and showed high homology to the 5' CpG island of the endothelin receptor B (EDNRB) gene. Since the EDNRB gene is commonly inactivated in prostate and bladder cancers, it may be a candidate target gene involved in NPC tumorigenesis. By bisulfite sequencing, we have confirmed that hypermethylation of the 5' CpG island of EDNRB occurred in both xenografts and all 4 cell lines but not in 2 normal nasopharyngeal outgrowths. RT-PCR demonstrated that only original EDNRB transcripts, but not the splicing transcripts, were expressed in normal nasopharyngeal epithelial cells. Loss of the original EDNRB expression was consistently found in 2 xenografts and 3 cell lines with dense methylation patterns. Treatment of these 3 cell lines with 5'-aza-2'-deoxycytidine led to re-expression of the EDNRB transcript and demethylation of its promoter regions. Our results demonstrate that silencing of EDNRB gene expression in NPC is associated with promoter hypermethylation. Using methylation-specific PCR, we also detected methylation of the 5' CpG island of EDNRB in 19/21 (90.5%) primary tumors, while no methylation was found in all 6 normal nasopharyngeal epithelia. The high frequencies of promoter hypermethylation suggest that repression of the EDNRB gene may play a role in the development of NPC. Copyright 2002 Wiley-Liss, Inc.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11920632     DOI: 10.1002/ijc.10271

Source DB:  PubMed          Journal:  Int J Cancer        ISSN: 0020-7136            Impact factor:   7.396


  15 in total

Review 1.  Early progress in epigenetic regulation of endothelin pathway genes.

Authors:  A K Welch; M E Jacobs; C S Wingo; B D Cain
Journal:  Br J Pharmacol       Date:  2013-01       Impact factor: 8.739

Review 2.  Endothelin receptor antagonists.

Authors:  Joel B Nelson
Journal:  World J Urol       Date:  2005-01-15       Impact factor: 4.226

Review 3.  Techniques used in studies of epigenome dysregulation due to aberrant DNA methylation: an emphasis on fetal-based adult diseases.

Authors:  Shuk-mei Ho; Wan-yee Tang
Journal:  Reprod Toxicol       Date:  2007-01-19       Impact factor: 3.143

4.  Promoter hypermethylation in Indian primary oral squamous cell carcinoma.

Authors:  Jatinder Kaur; Semra Demokan; Satyendra Chandra Tripathi; Muzafar Ahmad Macha; Shahnaz Begum; Joseph A Califano; Ranju Ralhan
Journal:  Int J Cancer       Date:  2010-11-15       Impact factor: 7.396

5.  Quantitative analysis of promoter methylation of the EDNRB gene in gastric cancer.

Authors:  Kaixiong Tao; Chuanqing Wu; Ke Wu; Wei Li; Gaoxiong Han; Xiaoming Shuai; Guobin Wang
Journal:  Med Oncol       Date:  2011-01-25       Impact factor: 3.064

Review 6.  DNA fingerprinting techniques for the analysis of genetic and epigenetic alterations in colorectal cancer.

Authors:  Johanna K Samuelsson; Sergio Alonso; Fumiichiro Yamamoto; Manuel Perucho
Journal:  Mutat Res       Date:  2010-09-17       Impact factor: 2.433

7.  Endothelin-1 inhibits apoptosis in prostate cancer.

Authors:  Joel B Nelson; Michael S Udan; Georgi Guruli; Beth R Pflug
Journal:  Neoplasia       Date:  2005-07       Impact factor: 5.715

8.  Endothelin receptor type B gene promoter hypermethylation in salivary rinses is independently associated with risk of oral cavity cancer and premalignancy.

Authors:  Kavita Malhotra Pattani; Zhe Zhang; Semra Demokan; Chad Glazer; Myriam Loyo; Steven Goodman; David Sidransky; Francisco Bermudez; Germain Jean-Charles; Thomas McCaffrey; Tapan Padhya; Joan Phelan; Silvia Spivakovsky; Helen Yoo Bowne; Judith D Goldberg; Linda Rolnitzky; Miriam Robbins; A Ross Kerr; David Sirois; Joseph A Califano
Journal:  Cancer Prev Res (Phila)       Date:  2010-08-26

9.  High-incidence spontaneous tumors in JF1/Ms mice: relevance of hypomorphic germline mutation and subsequent promoter methylation of Ednrb.

Authors:  Junko Watanabe; Yasuhiko Kaneko; Masafumi Kurosumi; Yasuhito Kobayashi; Michihiro Sakamoto; Mitsuaki A Yoshida; Miho Akiyama; Yoshibumi Matsushima
Journal:  J Cancer Res Clin Oncol       Date:  2013-11-06       Impact factor: 4.553

10.  Frequent loss of endothelin-3 (EDN3) expression due to epigenetic inactivation in human breast cancer.

Authors:  Frank Wiesmann; Jürgen Veeck; Oliver Galm; Arndt Hartmann; Manel Esteller; Ruth Knüchel; Edgar Dahl
Journal:  Breast Cancer Res       Date:  2009-06-15       Impact factor: 6.466

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.